Global Oxygen Therapy Market Size By Product (Oxygen Source Equipment, Oxygen Delivery Devices), By Portability (Stationary, Portable), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia), By Geographic Scope And Forecast

Oxygen Therapy Market Size And Forecast

Oxygen Therapy Market size was valued at USD 16.07 Billion in 2024 and is projected to reach USD 38.26 Billion by 2031, growing at a CAGR of 11.45% from 2024 to 2031.

• Oxygen therapy is a medical treatment that involves administering oxygen to individuals with difficulty breathing or low blood oxygen levels. It is given via various devices, including nasal cannulas, face masks, and ventilators.
• Oxygen therapy is used to treat chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and heart failure and to provide proper oxygenation during surgery.
• Furthermore, it improves blood oxygen saturation, reducing symptoms such as shortness of breath and exhaustion, and is vital in critical care settings for stabilizing and supporting patients with severe respiratory or cardiac problems.

Global Oxygen Therapy Market Dynamics

The key market dynamics that are shaping the oxygen therapy market include

Key Market Drivers

• Rising Chronic Disease RatesChronic obstructive pulmonary disease (COPD), congestive heart failure, and other chronic respiratory illnesses are on the rise worldwide. This rising prevalence increases the demand for oxygen therapy, which assists patients in managing symptoms such as shortness of breath and improving their overall quality of life.
• Aging Population As the global population ages, the prevalence of respiratory disorders such as COPD and pneumonia increases, driving up the need for oxygen therapy. This is seen in both acute care hospitals and long-term care homes, due to advances in home healthcare that improve patient comfort and accessibility.
• Technological AdvancementsPortable concentrators, which are lightweight and battery-powered, are propelling the oxygen therapy market forward, allowing patients to live active lifestyles. Advances in oxygen mask design improve comfort and efficiency, resulting in higher patient compliance. Telemedicine enables remote monitoring, lowering hospital readmissions and improving overall care management for patients receiving oxygen therapy.

Key Challenges

• High Costs Oxygen therapy is expensive, especially for long-term care, with concentrators, cylinders, refills, and supplies depleting patient funds. This financial burden causes people to postpone or skip necessary treatment, lowering health outcomes. In regions with limited healthcare resources, insufficient infrastructure and a lack of subsidies impede access to inexpensive oxygen therapy.
• Reimbursement Challenges Oxygen treatment reimbursement policies are complex and vary depending on the payer, patient condition, and equipment. This lack of consistency complicates the approval process, which delays coverage and has a negative impact on patient outcomes. Extensive paperwork requirements and precise coverage limitations generate ambiguity, making it difficult for providers to plan and budget for oxygen treatment services, thus limiting market growth.

Key Trends

• Shift Towards Home-Based Care The oxygen therapy market is shifting toward home-based care, thanks to developments in portable concentrators and remote monitoring technology. This transition decreases hospital readmissions and encourages a patient-centered approach, making it easier and less expensive for patients to get oxygen therapy at home.
• Telemedicine Integration Telemedicine is becoming increasingly important in oxygen treatment management since it allows for remote monitoring of patient vitals, oxygen levels, and therapy adherence. Early problem detection and teleconsultations improve access to specialist treatment and resolve problems, resulting in better patient outcomes and fewer consequences.
• Focus on Comfort and Convenience The market prioritizes oxygen delivery systems that are easy to use and pleasant. Lighter, quieter, and more inconspicuous concentrators and masks are being developed to increase patient comfort and convenience and to increase treatment adherence and quality of life for patients requiring oxygen therapy.
• Emerging TechnologiesThe oxygen therapy market is changing with new technologies such as liquid oxygen systems, non-invasive breathing techniques, and AI integration for tailored treatment regimens. These advancements promise to improve the efficacy and accessibility of oxygen therapy, resulting in better patient outcomes.

Global Oxygen Therapy Market Regional Analysis

Here is a more detailed regional analysis of the oxygen therapy market

North America

• According to Market Research, North America is estimated to dominate during the forecast period. North America’s high prevalence of chronic respiratory illnesses such as COPD and congestive heart failure increases demand for oxygen therapy equipment and services, as these conditions rely heavily on oxygen therapy for treatment.
• North America’s well-developed healthcare infrastructure, which includes several hospitals and specialist clinics outfitted with advanced oxygen therapy equipment, creates a wider market for these items by providing widespread access to sophisticated treatment alternatives.
• North America’s generous reimbursement policies for oxygen therapy, with insurance plans frequently covering equipment and supply prices, make treatment more accessible. This support promotes market expansion by making oxygen therapy more affordable to a larger patient population.
• Furthermore, North America’s renowned medical research institutions and innovation emphasis are driving the development of innovative oxygen therapy solutions. Continuous innovations in the sector result in more effective and user-friendly therapies, hence driving market growth.

Europe

• Europe region is estimated to exhibit substantial growth during the forecast period. Europe has a large population with chronic respiratory disorders such as COPD and asthma, which increases the demand for oxygen therapy to manage symptoms and improve quality of life. The aging population increases the requirement due to a higher vulnerability to respiratory problems.
• European countries generally have well-developed healthcare systems that provide high-quality care, including access to advanced diagnostic equipment and treatment alternatives such as oxygen therapy. This robust infrastructure facilitates the broad use of oxygen therapy, hence driving market growth.
• Furthermore, European businesses take the lead in creating innovative oxygen therapy technologies, which result in more efficient, portable, and user-friendly delivery systems. These improvements benefit patients and enhance the market for sophisticated oxygen therapy products.

Asia Pacific

• The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. Asia Pacific is experiencing an increase in the prevalence of chronic diseases such as COPD and diabetes, necessitating the use of oxygen treatment to manage symptoms. This growing patient pool creates a large demand for oxygen therapy devices and services in the region.
• Rapid aging in nations such as China and Japan raises the prevalence of age-related respiratory disorders, increasing the need for oxygen therapy for both acute hospitalization and long-term home use.
• Furthermore, Economic expansion in many Asian countries leads to greater healthcare investment and rising disposable incomes, making advanced medical technology, such as oxygen therapy, more accessible to a larger population.

Global Oxygen Therapy MarketSegmentation Analysis

The Oxygen Therapy Market is segmented based on Product, Portability, Application, and Geography.

Oxygen Therapy Market, Product

• Oxygen Source Equipment
  1. Oxygen Therapy Equipment for Cardiovascular & Thoracic Surgeries
  2. Oxygen Concentrators
  3. Liquid Oxygen
  4. Oxygen Cylinders

• Oxygen Delivery Devices
  1. Oxygen Maska
  2. Nasal Cannulas
  3. Venturi Masks
  4. Non-Rebreather Masks
  5. Bag-Valve Masks
  6. Others

Based on Product, the market is segmented into Oxygen Source Equipment and Oxygen Delivery Devices. The oxygen source equipment segment is estimated to dominate within the oxygen therapy market. Oxygen concentrators, which are the primary source of oxygen delivery in a variety of situations, serve as the foundation of oxygen therapy. The rising prevalence of chronic respiratory disorders demands a steady and dependable supply of oxygen, which oxygen concentrators and other source equipment deliver. While delivery devices such as masks and cannulas are required for oxygen administration, they are considered secondary parts that rely on oxygen source equipment to work. This reliance on oxygen source equipment for key functions underpins its market dominance.

Oxygen Therapy Market, By Portability

• Stationary
• Portable

Based on Portability, the Oxygen Therapy Market is divided into Stationary and Portable. The portability segment is estimated to dominate the market over the forecast period due to technology improvements that have resulted in lightweight, user-friendly portable oxygen concentrators that allow patients to live active lives while getting supplementary oxygen. The growing need for home-based care, driven by an older population and rising healthcare expenses, adds to the desire for portable choices. Furthermore, greater knowledge of the benefits of portability, such as improved patient comfort and quality of life, adds to the segment’s importance.

Oxygen Therapy Market, By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia
• Others

Based on Application, the Oxygen Therapy Market is divided into Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, and Others. The chronic obstructive pulmonary disease segment is estimated to dominate the market over the forecast period. COPD is a common chronic respiratory disorder with an increasing global patient population that needs long-term supplementary oxygen to manage symptoms and improve quality of life. The progressive nature of COPD, which worsens over time, necessitates a greater reliance on oxygen therapy as the disease proceeds. This consistent and increasing demand drives the COPD segment’s dominant market share in the oxygen therapy market.

Oxygen Therapy Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Oxygen Therapy Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate during the forecasted period. The region has a high frequency of chronic diseases such as COPD and heart failure, resulting in consistent demand for oxygen therapy. Advanced healthcare infrastructure enables widespread access to cutting-edge technology. Favorable reimbursement regulations make therapy more accessible, which boosts market growth. Furthermore, excellent research and development drives innovation, resulting in more effective treatment alternatives and a larger market for new technology. These factors support North America’s dominant position in the worldwide oxygen therapy market.

Key Players

The “Oxygen Therapy Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Linde plc, Chart Industries, Inc., Invacare Corporation, Philips Respironics, Inogen, Inc., DeVilbiss Healthcare LLC, Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare, GCE Group, and Taiyo Nippon Sanso Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Oxygen Therapy Market Recent Developments

• In November 2021, UNICEF collaborated with the UK government and Oxygen Colab to create a reliable oxygen concentrator for use in low-resource situations. This development occurs as an endeavor to combat the Coronavirus crisis and meet the demand for oxygen in critical care settings.
• In July 2021, Belluscura (BELL) signed its first and third distribution agreements for its X-PLO2RTM portable oxygen concentrators with a durable medical equipment manufacturer.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.